[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:serine-threonine-protein-kinase-lats1":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Serine\u002FThreonine-Protein Kinase LATS1",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06251310","SW-682 in Advanced Solid Tumors",[11],"Phase 1","RECRUITING","2026-08-26T02:18:38.077159Z","2026-05-05T02:43:28.970517Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05873686","A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers",[11],"2026-08-26T02:17:00.709807Z","2026-07-19T19:36:05.121267Z"]